Effects of acute salbutamol inhalation on quadriceps force and fatigability

Medicine and Science in Sports and Exercise

Volumn 40, Issue 7, 2008, Pages 1220-1227

  Decorte, Nicolas ^a   Verges, Samuel ^a,c   Flore, Patrice ^a   Guinot, Michel ^b   Wuyam, Bernard ^a  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Hopital Sud CHU de Grenoble   (France)

Author keywords

Beta2 agonist; Exercise; Muscle; Performance; Strength

Indexed keywords

PLACEBO; SALBUTAMOL;

ARTICLE; CONTROLLED STUDY; EXERCISE TEST; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NERVE STIMULATION; NORMAL HUMAN; QUADRICEPS FEMORIS MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ADMINISTRATION, INHALATION; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE STRENGTH; QUADRICEPS MUSCLE; RESPIRATORY FUNCTION TESTS; VITAL CAPACITY; YOUNG ADULT;

EID: 66149136437     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e31816b87aa     Document Type: Article

References (40)

1. Amoroso P, Wilson SR, Moxham J, Ponte J. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax. 1993;48:882-5.
2. Bassett DR, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32(1):70-84.
3. Beck KC, Joyner MJ, Scanlon PD. Exercise-induced asthma: diagnosis, treatment, and regulatory issues. Exerc Sport Sci Rev. 2002;30(1):1-3.
4. Bedi JF, Gong H Jr, Horvath SM. Enhancement of exercise performance with inhaled albuterol. Can J Sport Sci. 1988;13: 144-8.
5. Belmaker RH, Lerer B, Zohar J. Salbutamol treatment of depression. Adv Biochem Psychopharmacol. 1982;32:181-93.
6. Bigland-Ritchie B, Rice CL, Garland SJ, Walsh ML. Task-dependent factors in fatigue of human voluntary contractions. Adv Exp Med Biol. 1995;384:361-80.
7. Cairns SP, Dulhunty AF. beta-Adrenoceptor activation shows high-frequency fatigue in skeletal muscle fibers of the rat. Am J Physiol. 1994;266:C1204-9.
8. Carlsen KH, Ingjer F, Kirkegaard H, Thyness B. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes. Scand J Med Sci Sports. 1997;7:160-5.
9. Caruso JF, Signorile JF, Perry AC, et al. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc. 1995;27(11):1471-6.
10. Collomp K, Candau R, Collomp R, et al. Effects of acute ingestion of salbutamol during submaximal exercise. Int J Sports Med. 2000;21:480-4.
11. Collomp K, Le Panse B, Portier H, et al. Effects of acute salbutamol intake during a Wingate test. Int J Sports Med. 2005;26:513-7.
12. Du XL, Zhu Z, Fu Q, Li DK, Xu WB. Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers. Acta Pharmacol Sin. 2002;23:663-6.
13. Erdo SL, Kiss B, Rosdy B. The effect of salbutamol on the cerebral levels, uptake and turnover of serotonin. Eur J Pharmacol. 1982;78:357-61.
14. 2 and blood lactate. Int J Sports Med. 1993; 14:239-43.
15. Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev. 2001;81:1725-89.
16. Goldstein DA, Tan YK, Soldin SJ. Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol. 1987;32:631-4.
17. Gonzalez-Serratos H, Hill L, Valle-Aguilera R. Effects of catecholamines and cyclic AMP on excitation-contraction coupling in isolated skeletal muscle fibres of the frog. J Physiol. 1981;315:267-82.
18. Goubault C, Perault MC, Leleu E, et al. Effects of inhaled salbutamol in exercising non-asthmatic athletes. Thorax. 2001; 56:675-9.
19. Kindermann W. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes? Sports Med. 2007;37:95-102.
20. Kufel TJ, Pineda LA, Mador MJ. Comparison of potentiated and unpotentiated twitches as an index of muscle fatigue. Muscle Nerve. 2002;25:438-44.
21. Langdeau JB, Boulet LP. Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes. Sports Med. 2001;31:601-16.
22. Lanigan C, Howes TQ, Borzone G, Vianna LG, Moxham J. The effects of beta 2-agonists and caffeine on respiratory and limb muscle performance. Eur Respir J. 1993;6:1192-6.
23. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168:102-8.
24. Martineau L, Horan MA, Rothwell NJ, Little RA. Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond). 1992;83:615-21.
25. McKenzie DC, Rhodes EC, Stirling DR, et al. Salbutamol and treadmill performance in non-atopic athletes. Med Sci Sports Exerc. 1983;15(6):520-2.
26. Meeuwisse WH, McKenzie DC, Hopkins SR, Road JD. The effect of salbutamol on performance in elite nonasthmatic athletes. Med Sci Sports Exerc. 1992;24(10):1161-6.
27. Mikkelsen UR, Gissel H, Fredsted A, Clausen T. Excitation-induced cell damage and beta2-adrenoceptor agonist stimulated force recovery in rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2006;290:R265-72.
28. Norris SR, Petersen SR, Jones RL. The effect of salbutamol on performance in endurance cyclists. Eur J Appl Physiol Occup Physiol. 1996;73:364-8.
29. Pichon A, Venisse N, Krupka E, Perault-Pochat MC, Denjean A. Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of use. Int J Sports Med. 2006;27:187-92.
30. Price AH, Clissold SP. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs. 1989;38:77-122.
31. Reed CE. Physiology and pharmacology of beta2 adrenergic agents. Chest. 1978;73:914-8.
32. Shield A, Zhou S. Assessing voluntary muscle activation with the twitch interpolation technique. Sports Med. 2004;34:253-67.
33. Signorile JF, Barnes WS, Sams A, Ingalls C. The effects of the beta-2 agonist, fenoterol, on the biochemical and contractile properties of skeletal muscle. Med Sci Sports Exerc. 1989;20: S16.
34. Signorile JF, Kaplan TA, Applegate B, Perry AC. Effects of acute inhalation of the bronchodilator, albuterol, on power output. Med Sci Sports Exerc. 1992;24(6):638-42.
35. Simon P, Lecrubier Y, Jouvent R, Puech A, Widlocher D. Beta-receptor stimulation in the treatment of depression. Adv Biochem Psychopharmacol. 1984;39:293-9.
36. van Baak MA, de Hon OM, Hartgens F, Kuipers H. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. Int J Sports Med. 2004;25:533-8.
37. van Baak MA, Mayer LH, Kempinski RE, Hartgens F. Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc. 2000;32(7): 1300-6.
38. Van Der Heijden HF, Zhan WZ, Prakash YS, Dekhuijzen PN, Sieck GC. Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol. 1998;85:525-9.
39. Vivodtzev I, Flore P, Levy P, Wuyam B. Voluntary activation during knee extensions in severely deconditioned COPD patients: benefit of endurance training. Muscle Nerve. 2008;37:27-35.
40. Vivodtzev I, Wuyam B, Flore P, Levy P. Changes in quadriceps twitch tension in response to resistance training in healthy sedentary subjects. Muscle Nerve. 2005;32:326-34.